Inspections that yield a “No Action Indicated” status provide important regulatory intelligence that strengthens the safety net for American consumers, according to the FDA’s announcement.

The FDA is seeking public input on Operation Stork Speed, a review of and effort to improve the quality of infant formula. Health and Human Services Secretary Robert F. Kennedy Jr. says the ...

Many groups of people face new or added risks as a consequence of the FDA’s decision; notably, the agency has not signaled any intention to establish carveouts for caregivers of people who still ...

No use of the drug has received FDA approval as it can result in serious harm or death, Makary clarified. He emphasized the public must address the trend before it becomes the latest example of ...

Today, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) announced a new, joint innovative research initiative that will serve as a key element in fulfilling ...

The FDA’s proposed framework eerily mirrors the segmentation we attempted in fall 2021 with Covid boosters. When boosters initially rolled out in September 2021, the FDA authorized them only for ...

Seven weeks later, the FDA named Marks’ successor: Dr. Vinay Prasad, a hematologist and oncologist. That wouldn’t necessarily be a notable development from a political perspective, except ...

A May 19, 2025, news release from the FDA reports that 26 people across 15 states have become ill in the outbreak of salmonella montevideo. The cucumbers were grown by Bedner Growers ...

We surveyed ourselves—two middle-aged dads who love tech—and came up with this list of gifts we'd love to get this Father's ...

Previously, the only FDA-approved methods for detecting amyloid were invasive tests of spinal fluid or expensive PET scans. The lower costs and convenience of a blood test could also help expand ...

Experts say those who do not test positive for HPV, have virtually no risk of cervical cancer at that time and no further screening will be needed for three to five years. Some women are scared of ...

LONDON, May 14 (Reuters) - Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the ...